-
JPMorgan upgrades Bilibili (BILI) to Neutral; Citi downgrades, lowers estimates
-
Citi Downgrades Bilibili (BILI) to Neutral, 'Unexciting Outlook as Growth Moderates'
-
Citi Upgrades Bilibili (BILI) to Buy, 'Growth to Pick up from 2Q23 with Some Catalysts'
-
Today's Most Important Downgrades
-
Bilibili (BILI) Shares Down Over 6% Following Citi Downgrade
-
Citi Downgrades Bilibili (BILI) to Neutral
-
Bilibili (BILI) PT Lowered to $38 at Citi
-
Bilibili (BILI) PT Lowered to $45 at Citi
-
Pre-Open Stock Movers 09/09: (CURV) (CRDF) (LULU) Higher; (BASE) (SAM) (GME) Lower (more...)
-
Bilibili (BILI) PT Lowered to $20 at Citi
-
Citi Starts Bilibili (BILI) at Buy
-
New Research: Key Drivers of Growth for Castlight Health, inc, Citi Trends, Bilibili Inc. Sponsored ADR, CEVA, Duluth, and Exxon Mobil — Factors of Influence, Major Initiatives and Sustained Product
-
Citic Securities Starts Bilibili (BILI) at Overweight, 'Monetization Has Kicked Off'

